SEC 13F Intelligence

Lsv Asset Management / ALXN

Lsv Asset Management’s Alexion Pharmaceuticals Inc Position

Does Lsv Asset Management own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 1.71M shares worth $314M in Q2 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$314M
Q2 2021
Shares
1.71M
% of Portfolio
+0.53%
Quarters Held
8
position exited

Position History ALXN

Reported value by quarter
Q3 ’19: $861,000Q3 ’19Q4 ’19: $73MQ4 ’19Q1 ’20: $76MQ1 ’20Q2 ’20: $393MQ2 ’20Q3 ’20: $405MQ3 ’20Q4 ’20: $525MQ4 ’20Q1 ’21: $397MQ1 ’21Q2 ’21: $314MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20211.71M$314M+0.53%
Q1 20212.60M$397M+0.68%
Q4 20203.36M$525M+0.95%
Q3 20203.54M$405M+0.83%
Q2 20203.50M$393M+0.81%
Q1 2020849.4K$76M+0.18%
Q4 2019670.8K$73M+0.11%
Q3 20198.8K$861,0000.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lsv Asset Management’s full portfolio or all institutional holders of ALXN.